{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:48:15Z","timestamp":1782276495561,"version":"3.54.5"},"reference-count":89,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chumakov FSC R&amp;D IBP RAS (Institute of Poliomyelitis) fundamental research assignment","award":["FNZG-2024-0008, . FNZG-2024-0004"],"award-info":[{"award-number":["FNZG-2024-0008, . FNZG-2024-0004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ranges of distribution of some orthoflaviviruses, including the Omsk hemorrhagic fever virus (OHFV) and the Powassan virus (POWV), have been identified in the range endemic for the tick-borne encephalitis virus (TBEV). In contrast to TBEV, no registered vaccine against OHFV and POWV is currently available. Nevertheless, recent studies have indicated that the anti-TBEV vaccine may offer partial protection against other orthoflaviviruses. The present study assesses OHFV and POWV infection in an experimental model on BALB\/c mice one, three- and twelve-months post-immunization with inactivated TBE vaccine. The TBE vaccine was shown to provide long-term protection against OHFV and partial protection against POWV, even in the absence of specific antibodies, and without indications of antibody-dependent enhancement of infection. The neutralizing antibody titer for OHFV in vaccinated animals before and after the challenge with OHFV was similar to the titer of antibodies against the TBEV vaccine strain. Following immunization with anti-TBEV vaccine and subsequent inoculation of POWV, the levels of neutralizing antibodies against the TBEV vaccine strain was observed to be higher compared to those targeting POWV, especially during the initial phase of infection. Such cross-reactive antibodies have potential to pose a significant diagnostic challenge in cases where an infection is occurring simultaneously with an immune response to another virus.<\/jats:p>","DOI":"10.3390\/ijms27125435","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:27:21Z","timestamp":1781666841000},"page":"5435","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Omsk Hemorrhagic Fever Virus and Powassan Virus Infections at Different Times After Immunization with the TBE Vaccine in In Vivo Experiments"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4080-4196","authenticated-orcid":false,"given":"Viktoria","family":"Kuchina","sequence":"first","affiliation":[{"name":"Laboratory of Biology of Arboviruses, Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), Moscow 108819, Russia"},{"name":"Faculty of Biology, Lomonosov Moscow State University, Moscow 119234, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5668-3603","authenticated-orcid":false,"given":"Ksenia","family":"Tuchynskaya","sequence":"additional","affiliation":[{"name":"Laboratory of Biology of Arboviruses, Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), Moscow 108819, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Rogova","sequence":"additional","affiliation":[{"name":"Laboratory of Biology of Arboviruses, Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), Moscow 108819, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8901-6206","authenticated-orcid":false,"given":"Galina","family":"Karganova","sequence":"additional","affiliation":[{"name":"Laboratory of Biology of Arboviruses, Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), Moscow 108819, Russia"},{"name":"Faculty of Biology, Lomonosov Moscow State University, Moscow 119234, Russia"},{"name":"Institute for Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"ref_1","unstructured":"(2025, September 05). Virus Taxonomy: 2024 Release. Available online: https:\/\/ictv.global\/taxonomy."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e2470","DOI":"10.1002\/rmv.2470","article-title":"Tick-borne encephalitis: A comprehensive review of the epidemiology, virology, and clinical picture","volume":"33","author":"Chiffi","year":"2023","journal-title":"Rev. Med. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.18821\/0507-4088-2016-61-3-135-139","article-title":"Vaccines based on the Far-Eastern and European strains induce the neutralizing antibodies against all known tick-borne encephalitis virus subtypes","volume":"61","author":"Maikova","year":"2016","journal-title":"Probl. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.tmaid.2010.06.004","article-title":"Tick-borne encephalitis: Pathogenesis and clinical implications","volume":"8","author":"Dobler","year":"2010","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_5","unstructured":"Shapoval, A.N. (1980). Tick-Borne Encephalomyelitis, Medicine."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0264-410X(02)00811-3","article-title":"Tick-borne encephalitis\u2014Pathogenesis, clinical course and long-term follow-up","volume":"21","author":"Haglund","year":"2003","journal-title":"Vaccine"},{"key":"ref_7","first-page":"10","article-title":"Chronic tick-borne encephalitis","volume":"5","author":"Demianovskaia","year":"2021","journal-title":"Lechaschi Vrach"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Volok, V.P., Gmyl, L.V., Belyaletdinova, I.K., Karganova, G.G., and Dekonenko, E.P. (2022). Progressive Course of Chronic Tick-Borne Encephalitis Manifesting as Amyotrophic Lateral Sclerosis-like Syndrome 35 Years after the Acute Disease. Brain Sci., 12.","DOI":"10.3390\/brainsci12081020"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13365-023-01182-8","article-title":"Genetic polymorphisms in innate immunity genes influence predisposition to tick-borne encephalitis","volume":"29","author":"Fortova","year":"2023","journal-title":"J. Neurovirol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2019.01.014","article-title":"Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines","volume":"164","author":"Ruzek","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1134\/S0026893319020031","article-title":"New Genetic Marker of Human Predisposition to Severe Forms of Tick-Borne Encephalitis","volume":"53","author":"Barkhash","year":"2019","journal-title":"Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Shi, J., Shen, A., Cheng, Y., Zhang, C., and Yang, X. (2023). 30-Year Development of Inactivated Virus Vaccine in China. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15122721"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4161\/hv.20058","article-title":"Antibody persistence after two vaccinations with either FSME-IMMUN\u00ae Junior or ENCEPUR\u00ae Children followed by third vaccination with FSME-IMMUN\u00ae Junior","volume":"8","author":"Prymula","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1016\/j.vaccine.2014.02.046","article-title":"Evaluation of immune response and protective effect of four vaccines against the tick-borne encephalitis virus","volume":"32","author":"Morozova","year":"2014","journal-title":"Vaccine"},{"key":"ref_15","unstructured":"(2025, May 10). Rospotrebnadzor Reported That More Than 2.3 Million Russians Have Been Vaccinated Against Tick-Borne Encephalitis. Available online: https:\/\/tass.ru\/obschestvo\/20729289."},{"key":"ref_16","first-page":"6","article-title":"Epidemiological Situation on Tick-Borne Viral Encephalitis in the Russian Federation in 2022 and Forecast of its Development for 2023","volume":"1","author":"Andaev","year":"2023","journal-title":"Probl. Part. Danger. Infect."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Aberle, J.H., Schwaiger, J., Aberle, S.W., Stiasny, K., Scheinost, O., Kundi, M., Chmelik, V., and Heinz, F.X. (2015). Human CD4+ T Helper Cell Responses after Tick-Borne Encephalitis Vaccination and Infection. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140545"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e70027","DOI":"10.1002\/eji.70027","article-title":"Human T Cell Responses to Flavivirus Vaccines","volume":"55","author":"Wullimann","year":"2025","journal-title":"Eur. J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Sycheva, A.L., Komech, E.A., Pogorelyy, M.V., Minervina, A.A., Urazbakhtin, S.Z., Salnikova, M.A., Vorovitch, M.F., Kopantzev, E.P., Zvyagin, I.V., and Komkov, A.Y. (2022). Inactivated tick-borne encephalitis vaccine elicits several overlapping waves of T cell response. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.970285"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.36233\/0372-9311-553","article-title":"The importance of the role of T-cell immunity in the development of modern tick-borne encephalitis vaccines","volume":"101","author":"Tigeeva","year":"2024","journal-title":"J. Microbiol. Epidemiol. Immunobiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/vbz.2023.0156","article-title":"The First Record of Omsk Hemorrhagic Fever Virus and Tick-Borne Encephalitis Virus of Baltic Lineage from the Kemerovo Region of Russia","volume":"24","author":"Kovalev","year":"2024","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"ref_22","first-page":"13","article-title":"West Nile fever on the territory of the Moscow agglomeration","volume":"10","author":"Klimova","year":"2021","journal-title":"Infect. Dis. News Opin. Train."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcma.2014.12.009","article-title":"Current recommendations for the Japanese encephalitis vaccine","volume":"78","author":"Chen","year":"2015","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_24","first-page":"173","article-title":"Role of Powassan virus in the etiological structure of tick-borne encephalitis in the Primorsky Kray","volume":"2","author":"Leonova","year":"1980","journal-title":"Vopr. Virusol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Wagner, E., Shin, A., Tukhanova, N., Turebekov, N., Nurmakhanov, T., Sutyagin, V., Berdibekov, A., Maikanov, N., Lezdinsh, I., and Shapiyeva, Z. (2022). First Indications of Omsk Haemorrhagic Fever Virus beyond Russia. Viruses, 14.","DOI":"10.3390\/v14040754"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/zph.12941","article-title":"Tick-borne encephalitis virus and West-Nile fever virus as causes of serous meningitis of unknown origin in Kazakhstan","volume":"69","author":"Shin","year":"2022","journal-title":"Zoonoses Public Health"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/S0140-6736(10)61120-8","article-title":"Omsk haemorrhagic fever","volume":"376","author":"Yakimenko","year":"2010","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00705-009-0376-y","article-title":"Characterization of Powassan viruses from Far Eastern Russia","volume":"154","author":"Leonova","year":"2009","journal-title":"Arch. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.idc.2022.03.003","article-title":"Powassan virus encephalitis","volume":"36","author":"Piantadosi","year":"2023","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Cimica, V., Saleem, S., Matuczinski, E., Adams-Fish, D., McMahon, C., Rashid, S., and Stedman, T.T. (2021). A Virus-Like Particle-Based Vaccine Candidate against the Tick-Borne Powassan Virus Induces Neutralizing Antibodies in a Mouse Model. Pathogens, 10.","DOI":"10.3390\/pathogens10060680"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Cheung, A.M., Yip, E.Z., Ashbrook, A.W., Goonawardane, N., Quirk, C., Rice, C.M., MacDonald, M.R., and Hoffmann, H.H. (2023). Characterization of Live-Attenuated Powassan Virus Vaccine Candidates Identifies an Efficacious Prime-Boost Strategy for Mitigating Powassan Virus Disease in a Murine Model. Vaccines, 11.","DOI":"10.3390\/vaccines11030612"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"101627","DOI":"10.1016\/j.ttbdis.2020.101627","article-title":"Molecular variability and genetic structure of Omsk hemorrhagic fever virus, based on analysis of the complete genome sequences","volume":"12","author":"Kovalev","year":"2021","journal-title":"Ticks Tick-Borne Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1099\/vir.0.024232-0","article-title":"Molecular epidemiology of Powassan virus in North America","volume":"91","author":"Pesko","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/0972-9062.308794","article-title":"Geographic distribution of Tick-borne encephalitis virus complex","volume":"57","author":"Im","year":"2020","journal-title":"J. Vector Borne Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/vbz.2017.2110","article-title":"Powassan Virus: An Emerging Arbovirus of Public Health Concern in North America","volume":"17","author":"Hermance","year":"2017","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Deviatkin, A.A., Aleshina, Y.A., Karganova, G.G., and Lukashev, A.N. (2024). Selection Pressure Profile Suggests Species Criteria among Tick-Borne Orthoflaviviruses. Viruses, 16.","DOI":"10.3390\/v16101554"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2006.09.015","article-title":"Genetic characterization of tick-borne flaviviruses: New insights into evolution, pathogenetic determinants and taxonomy","volume":"361","author":"Grard","year":"2007","journal-title":"Virology"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Pripuzova, N.S., Gmyl, L.V., Romanova, L.I., Tereshkina, N.V., Rogova, Y.V., Terekhina, L.L., Kozlovskaya, L.I., Vorovitch, M.F., Grishina, K.G., and Timofeev, A.V. (2013). Exploring of Primate Models of Tick-Borne Flaviviruses Infection for Evaluation of Vaccines and Drugs Efficacy. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061094"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Illarionova, V., Rogova, A., Tuchynskaya, K., Volok, V., Rogova, Y., Baryshnikova, V., Turchenko, Y., Litov, A., Kalyanova, A., and Siniugina, A. (2023). Inapparent Tick-Borne Orthoflavivirus Infection in Macaca fascicularis: A Model for Antiviral Drug and Vaccine Research. Vaccines, 11.","DOI":"10.3390\/vaccines11121754"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.vaccine.2016.03.041","article-title":"Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin","volume":"34","author":"Chernokhaeva","year":"2016","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/1348-0421.12122","article-title":"Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus","volume":"58","author":"Chidumayo","year":"2014","journal-title":"Microbiol. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/infdis\/jir122","article-title":"A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans","volume":"203","author":"Orlinger","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41541-017-0009-5","article-title":"Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and\/or infection","volume":"2","author":"McAuley","year":"2017","journal-title":"npj Vaccines"},{"key":"ref_44","first-page":"57371","article-title":"A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum","volume":"134","author":"Valiant","year":"2018","journal-title":"J. Vis. Exp."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4269\/ajtmh.1988.38.411","article-title":"Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants","volume":"38","author":"Kliks","year":"1988","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Haslwanter, D., Blaas, D., Heinz, F.X., and Stiasny, K. (2017). A novel mechanism of antibody-mediated enhancement of flavivirus infection. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006643"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sawant, J., Patil, A., and Kurle, S. (2023). A Review: Understanding Molecular Mechanisms of Antibody-Dependent Enhancement in Viral Infections. Vaccines, 11.","DOI":"10.3390\/vaccines11071240"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.molimm.2022.11.010","article-title":"Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis","volume":"152","author":"Thomas","year":"2022","journal-title":"Mol. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","article-title":"The role of IgG Fc receptors in antibody-dependent enhancement","volume":"20","author":"Bournazos","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"eaav3208","DOI":"10.1126\/sciadv.aav3208","article-title":"Maternal immunity and antibodies to dengue virus promote infection and Zika virus-induced microcephaly in fetuses","volume":"5","author":"Rathore","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/cti.2016.72","article-title":"Dengue virus antibodies enhance Zika virus infection","volume":"5","author":"Paul","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1038\/s41598-017-10901-1","article-title":"Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques","volume":"7","author":"George","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"16164","DOI":"10.1038\/nmicrobiol.2016.164","article-title":"Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity","volume":"1","author":"Chan","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1016\/j.vaccine.2017.09.089","article-title":"Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age","volume":"35","author":"Halstead","year":"2017","journal-title":"Vaccine"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Tuchynskaya, K., Volok, V., Illarionova, V., Okhezin, E., Polienko, A., Belova, O., Rogova, A., Chernokhaeva, L., and Karganova, G. (2021). Experimental assessment of possible factors associated with tick-borne encephalitis vaccine failure. Microorganisms, 9.","DOI":"10.3390\/microorganisms9061172"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femspd\/ftu002","article-title":"Anti-tick-borne encephalitis (TBE) virus neutralizing antibodies dynamics in natural infections versus vaccination","volume":"73","author":"Remoli","year":"2015","journal-title":"Pathog. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"13845","DOI":"10.1128\/JVI.02086-14","article-title":"Variation of the Specificity of the Human Antibody Responses after Tick-Borne Encephalitis Virus Infection and Vaccination","volume":"88","author":"Jarmer","year":"2014","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1089\/vbz.2012.1231","article-title":"Genetic and Biological Characterization of Tick-Borne Encephalitis Virus Isolated from Wild Rodents in Southern Hokkaido, Japan in 2008","volume":"13","author":"Kentaro","year":"2013","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.virol.2009.04.026","article-title":"Mortality following peripheral infection with Tick-borne encephalitis virus results from a combination of central nervous system pathology, systemic inflammatory and stress responses","volume":"390","author":"Hayasaka","year":"2009","journal-title":"Virology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1292\/jvms.09-0258","article-title":"Early Mortality Following Intracerebral Infection with the Oshima Strain of Tick-Borne Encephalitis Virus in a Mouse Model","volume":"72","author":"Hayasaka","year":"2010","journal-title":"J. Vet. Med. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Chernokhaeva, L.L., Rogova, Y.V., Kozlovskaya, L.I., Romanova, L.I., Osolodkin, D.I., Vorovitch, M.F., and Karganova, G.G. (2018). Experimental Evaluation of the Protective Efficacy of Tick-Borne Encephalitis (TBE) Vaccines Based on European and Far-Eastern TBEV Strains in Mice and in Vitro. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01487"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11357-011-9371-9","article-title":"Mechanistic insights into the impairment of memory B cells and antibody production in the elderly","volume":"35","author":"Aberle","year":"2013","journal-title":"AGE"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s15010-023-02023-w","article-title":"Recovery and sequelae in 523 adults and children with tick-borne encephalitis in Germany","volume":"51","author":"Nygren","year":"2023","journal-title":"Infection"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/j.vaccine.2010.02.001","article-title":"Vaccine failures after active immunisation against tick-borne encephalitis","volume":"28","author":"Andersson","year":"2010","journal-title":"Vaccine"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/B978-012369454-6\/50074-1","article-title":"Mouse Models in Aging Research","volume":"Volume III","author":"Flurkey","year":"2007","journal-title":"The Mouse in Biomedical Research"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/brv.12243","article-title":"The effects of sex hormones on immune function: A meta-analysis: Sex hormones and immune function","volume":"92","author":"Foo","year":"2017","journal-title":"Biol. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1128\/iai.9.6.1123-1125.1974","article-title":"Influence of Sex and Age on Natural Resistance to St. Louis Encephalitis Virus Infection in Mice","volume":"9","author":"Andersen","year":"1974","journal-title":"Infect. Immun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e00560-24","DOI":"10.1128\/jvi.00560-24","article-title":"Age-dependent Powassan virus lethality is linked to glial cell activation and divergent neuroinflammatory cytokine responses in a murine model","volume":"98","author":"Mladinich","year":"2024","journal-title":"J. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41467-023-44667-0","article-title":"Bystander activated CD8+ T cells mediate neuropathology during viral infection via antigen-independent cytotoxicity","volume":"15","author":"Balint","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e03606-22","DOI":"10.1128\/mbio.03606-22","article-title":"Of Murines and Humans: Modeling Persistent Powassan Disease in C57BL\/6 Mice","volume":"14","author":"Scroggs","year":"2023","journal-title":"mBio"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4049\/jimmunol.1801149","article-title":"Original Antigenic Sin: How First Exposure Shapes Lifelong Anti\u2013Influenza Virus Immune Responses","volume":"202","author":"Zhang","year":"2019","journal-title":"J. Immunol."},{"key":"ref_75","first-page":"572","article-title":"On the doctrine of original antigenic sin","volume":"104","author":"Francis","year":"1960","journal-title":"Proc. Am. Philos. Soc."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/jmv.21524","article-title":"Clinical evaluation of highly pathogenic tick-borne flavivirus infection in the mouse model","volume":"81","author":"Tigabu","year":"2009","journal-title":"J. Med. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/NEN.0000000000000166","article-title":"The Pathogenesis of 3 Neurotropic Flaviviruses in a Mouse Model Depends on the Route of Neuroinvasion After Viremia","volume":"74","author":"Nagata","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/v3122374","article-title":"The Human Antibody Response to Dengue Virus Infection","volume":"3","author":"Wahala","year":"2011","journal-title":"Viruses"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15252\/embr.201745302","article-title":"The bright and the dark side of human antibody responses to flaviviruses: Lessons for vaccine design","volume":"19","author":"Rey","year":"2018","journal-title":"EMBO Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"12187","DOI":"10.1128\/JVI.01690-13","article-title":"Aluminum Hydroxide Influences Not Only the Extent but Also the Fine Specificity and Functional Activity of Antibody Responses to Tick-Borne Encephalitis Virus in Mice","volume":"87","author":"Zlatkovic","year":"2013","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/labmed\/lmx050","article-title":"Coagulation Testing in the Core Laboratory","volume":"48","author":"Winter","year":"2017","journal-title":"Lab. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1177\/1076029618806424","article-title":"Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies","volume":"24","author":"Papageorgiou","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tcm.2015.12.001","article-title":"Tissue factor as a link between inflammation and coagulation","volume":"26","author":"Witkowski","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Adane, T., and Getawa, S. (2021). Coagulation abnormalities in Dengue fever infection: A systematic review and meta-analysis. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009666"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.thromres.2013.09.028","article-title":"Hemostatic derangement in dengue hemorrhagic fever","volume":"133","author":"Chuansumrit","year":"2014","journal-title":"Thromb. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5323428","DOI":"10.1155\/2019\/5323428","article-title":"Comparison of the Immunogenicity and Safety of Two Pediatric TBE Vaccines Based on the Far Eastern and European Virus Subtypes","volume":"2019","author":"Vorovitch","year":"2019","journal-title":"Adv. Virol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"ref_88","first-page":"321","article-title":"Laboratory techniques in rabies: Methods of calculation","volume":"23","author":"Lorenz","year":"1973","journal-title":"Monogr. Ser. World Health Organ."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.virol.2006.12.013","article-title":"Microevolution of tick-borne encephalitis virus in course of host alternation","volume":"362","author":"Romanova","year":"2007","journal-title":"Virology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5435\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:18:44Z","timestamp":1782274724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":89,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27125435"],"URL":"https:\/\/doi.org\/10.3390\/ijms27125435","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}